AI assistant
Sending…
Propanc Biopharma, Inc. — Director's Dealing 2012
Aug 6, 2012
34906_dirs_2012-08-06_6fe0c96a-3263-40d2-aec5-9424d8721b04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2012-07-16
Reporting Person: Kenyon Julian Norman (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Shares in Propanc Health Group Corp. | 2703016 | Direct |
More from Propanc Biopharma, Inc.
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Mar 19
Board/Management Information
2026
Feb 26
Interim / Quarterly Report
2026
Feb 17
Capital/Financing Update
2026
Feb 2
Delisting Announcement
2026
Jan 7
Capital/Financing Update
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 10